CoChat

BDNF Depresses Excitability of Parvalbumin-Positive Interneurons through an M-Like Current in Rat Dentate Gyrus

Open access
Nieto-Gonzalez, Jose Luis, Jensen, Kimmo · 2013 · PLoS ONE

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

In addition to their classical roles in neuronal growth, survival and differentiation, neurotrophins are also rapid regulators of excitability, synaptic transmission and activity-dependent synaptic plasticity. We have recently shown that mature BDNF (Brain Derived Neurotrophic Factor), but not proBDNF, modulates the excitability of interneurons in dentate gyrus within minutes. Here, we used brain slice patch-clamp recordings to study the mechanisms through which BDNF modulates the firing of interneurons in rat dentate gyrus by binding to TrkB receptors. Bath application of BDNF (15 ng/ml) under current-clamp decreased the firing frequency (by 80%) and input resistance, blocking the delayed firing observed at near-threshold voltage ranges, with no changes in resting membrane potential or action potential waveform. Using TEA (tetraethylammonium), or XE991(a Kv7/KCNQ channel antagonist), the effect of BDNF was abolished, whereas application of retigabine (a Kv7/KCNQ channel opener) mimicked the effect of BDNF, suggesting that the M-current could be implicated in the modulation of the firing. In voltage-clamp experiments, BDNF increased the M-like current amplitude with no change in holding current. This effect was again blocked by XE991 and mimicked by retigabine, the latter accompanied with a change in holding current. In agreement with the electrophysiology, parvalbumin-positive interneurons co-expressed TrkB receptors and Kv7.2/KCNQ2 channels. In conclusion, BDNF depresses the excitability of interneurons by activating an M-like current and possibly blocking Kv1 channels, thereby controlling interneuron resting membrane potential and excitability.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0067318

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Identification of parvalbumin-positive interneurons and effect of BDNF on firing properties. A. Confocal image showing the co-localization of an intracellularly biocytin-labeled interneuron (green) and immunoreactivity for parvalbumin (red). B. Current-clamp recording from a parvalbumin-positive interneuron showing the firing before and after 10 min of bath perfusion of BDNF (15 ng/ml). The neuron was depolarized by a 200 pA current injection for 500 ms. Arrowhead indicates a delayed firing observed in the interneuron near the current threshold. C. The time course of the evoked firing (black y axis) and resting membrane potential (blue y axis) of an interneuron exposed to BDNF (black and blue circles) and a time-matched control (black and blue squares) exposed to control ACSF. The time of BDNF application is indicated by the solid line. D. Relationship between the firing frequency versus increasing current steps (0–400 pA) for control (squares) and after 10 min of BDNF exposure (circles) (n = 8).
Figure 1 Identification of parvalbumin-positive interneurons and effect of BDNF on firing properties. A. Confocal image showing the co-localization of an intracellularly biocytin-labeled interneuron (green) and immunoreactivity for parvalbumin (red). B. Current-clamp recording from a parvalbumin-positive interneuron showing the firing before and after 10 min of bath perfusion of BDNF (15 ng/ml). The neuron was depolarized by a 200 pA current injection for 500 ms. Arrowhead indicates a delayed firing observed in the interneuron near the current threshold. C. The time course of the evoked firing (black y axis) and resting membrane potential (blue y axis) of an interneuron exposed to BDNF (black and blue circles) and a time-matched control (black and blue squares) exposed to control ACSF. The time of BDNF application is indicated by the solid line. D. Relationship between the firing frequency versus increasing current steps (0–400 pA) for control (squares) and after 10 min of BDNF exposure (circles) (n = 8).CC BY · PubMed Central
Figure 2 Action potential waveform is not affected by BDNF. A. Average action potential waveform before (black trace) and after (grey trace) bath application of BDNF (151ng/ml). B. Histogram showing no significant difference in the action potential half width in control and BDNF. C. Graph illustrating a representative phase plot of dV/dt versus voltage of 20 action potentials before (black lines) and after bath application of BDNF (grey lines). Insets illustrate the overlay of the 20 action potentials. D. Histogram showing no significant difference for dV/dt negative peak in both conditions control and exposed to BDNF (n = 8, P>0.05).
Figure 2 Action potential waveform is not affected by BDNF. A. Average action potential waveform before (black trace) and after (grey trace) bath application of BDNF (151ng/ml). B. Histogram showing no significant difference in the action potential half width in control and BDNF. C. Graph illustrating a representative phase plot of dV/dt versus voltage of 20 action potentials before (black lines) and after bath application of BDNF (grey lines). Insets illustrate the overlay of the 20 action potentials. D. Histogram showing no significant difference for dV/dt negative peak in both conditions control and exposed to BDNF (n = 8, P>0.05).CC BY · PubMed Central
Figure 3 BDNF modulates M current. A. Current-clamp recordings showing evoked firing before and after bath application of BDNF (15 ng/ml) in presence of XE991 (10 µM), which blocked the neurotrophin effect. In agreement with the involvement of IM, the Kv7/KCNQ potentiator retigabine (10 µM) depressed interneuron firing. B. Histogram showing the effect of BDNF (15 ng/ml) in the presence of a broad spectrum potassium channels antagonist (TEA, 20 mM), the specific IM blocker (XE991, 10 µM), or application of retigabine (10 µM) on the normalized firing of parvalbumin-positive interneurons. Note that XE991 blocked the effect of the BDNF while retigabine mimicked the effect of BDNF. C. Histogram depicting the effect of BDNF (15 ng/ml) on the normalized firing of interneurons recorded with an intracellular solution containing different inhibitors of intracellular cascades (BAPTA, 10 mM, GDP-β-S, 1 mM or U73122, 1 µM). The firing increased after application of BDNF in interneurons recorded with an intracellular G protein inhibitor (GDP-β-S) or a PLC inhibitor (U73122).
Figure 3 BDNF modulates M current. A. Current-clamp recordings showing evoked firing before and after bath application of BDNF (15 ng/ml) in presence of XE991 (10 µM), which blocked the neurotrophin effect. In agreement with the involvement of IM, the Kv7/KCNQ potentiator retigabine (10 µM) depressed interneuron firing. B. Histogram showing the effect of BDNF (15 ng/ml) in the presence of a broad spectrum potassium channels antagonist (TEA, 20 mM), the specific IM blocker (XE991, 10 µM), or application of retigabine (10 µM) on the normalized firing of parvalbumin-positive interneurons. Note that XE991 blocked the effect of the BDNF while retigabine mimicked the effect of BDNF. C. Histogram depicting the effect of BDNF (15 ng/ml) on the normalized firing of interneurons recorded with an intracellular solution containing different inhibitors of intracellular cascades (BAPTA, 10 mM, GDP-β-S, 1 mM or U73122, 1 µM). The firing increased after application of BDNF in interneurons recorded with an intracellular G protein inhibitor (GDP-β-S) or a PLC inhibitor (U73122).CC BY · PubMed Central
Figure 4 Voltage-clamp experiments reveal that an M-like current is potentiated by BDNF. A. Under voltage-clamp conditions stepping the membrane from –30 to –50 mV, BDNF (15 ng/ml) increased the IM amplitude. Dashed lines indicate single exponential fits from which the IM amplitude was obtained. B. Plots of IM amplitude and holding current (Ihold) are shown in different conditions. Again, retigabine mimicked the potentiating effect of BDNF on IM amplitude.
Figure 4 Voltage-clamp experiments reveal that an M-like current is potentiated by BDNF. A. Under voltage-clamp conditions stepping the membrane from –30 to –50 mV, BDNF (15 ng/ml) increased the IM amplitude. Dashed lines indicate single exponential fits from which the IM amplitude was obtained. B. Plots of IM amplitude and holding current (Ihold) are shown in different conditions. Again, retigabine mimicked the potentiating effect of BDNF on IM amplitude.CC BY · PubMed Central
Figure 5 Co-localization of TrkB receptors and Kv7.2/KCNQ2 channels in parvalbumin-positive interneurons in rat dentate gyrus. A. Double immunohistochemistry showing the distribution of parvalbumin-positive interneurons (green) and Kv7.2/KCNQ2 channels (red) in dentate gyrus. B. Triple immunohistochemistry indicating the co-localization of TrkB receptors (green), Kv7.2/KCNQ2 channels (red) and parvalbumin-positive interneurons (blue).
Figure 5 Co-localization of TrkB receptors and Kv7.2/KCNQ2 channels in parvalbumin-positive interneurons in rat dentate gyrus. A. Double immunohistochemistry showing the distribution of parvalbumin-positive interneurons (green) and Kv7.2/KCNQ2 channels (red) in dentate gyrus. B. Triple immunohistochemistry indicating the co-localization of TrkB receptors (green), Kv7.2/KCNQ2 channels (red) and parvalbumin-positive interneurons (blue).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Cited by

See all 35

Metadata

Authors
Nieto-Gonzalez, J. L., & Jensen, K.
Affiliations
Aarhus University (DK)
Venue
PLoS ONE
Published
2013-06-19
Volume
8
Issue
6
Pages
e67318
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2079353635
Cited by
35
References
39
Citations by year
2026: 1 · 2024: 1 · 2023: 2 · 2022: 6 · 2021: 1 · 2020: 5 · 2019: 4 · 2017: 7 · 2016: 2 · 2015: 2 · 2014: 4
FWCI
1.31
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Sundhed og Sygdom, Det Frie Forskningsråd
  • Lundbeckfonden
  • H. Lundbeck A/S
  • Medical Research Council
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
Keywords
brain-derived neurotrophic factor, parvalbumin interneurons, dentate gyrus, neuronal excitability, Kv1 channels, TrkB receptor, retigabine, tetraethylammonium, input resistance, resting membrane potential, neurotrophins
MeSH terms
Action Potentials, Animals, Female, Interneurons, Male, Parvalbumins, Type C Phospholipases, Rats, Wistar, Patch-Clamp Techniques, Dentate Gyrus, GTP-Binding Proteins, Brain-Derived Neurotrophic Factor, Potassium Channel Blockers, Rats, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: BDNF Depresses Excitability of Parvalbumin-Positive Interneurons through an M-Like Current in Rat Dentate Gyrus. https://app.cochat.ai/papers/10.1371/journal.pone.0067318
The paper
Nieto-Gonzalez, J. L., & Jensen, K. (2013). BDNF Depresses Excitability of Parvalbumin-Positive Interneurons through an M-Like Current in Rat Dentate Gyrus. PLoS ONE. https://doi.org/10.1371/journal.pone.0067318

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.